Abstract: A controller for a storage device is connected to a host system and the storage device. A buffer memory includes first and second storage areas. A timer counts a preset given time in response to an instruction to start counting and sends a deadline notification when A given time is elapsed. A command responding portion, when receiving a read command from the host system, instructs the timer to start counting and thereafter outputs a read instruction to read data from the storage system. A data processing portion, in response to the read instruction by the command responding portion, reads specified data from the storage device and holds the read data in the second storage area of the buffer memory. A read control portion sends the host system the data held in the second storage area of the buffer memory when the deadline notification is received from the timer.

Abstract: According to one embodiment, a controller for a storage apparatus is disclosed having interfaces connectable to a host system, a first storage apparatus and a second storage apparatus. A data in the first storage apparatus and a data in the second storage apparatus are duplicates. A status table stores the operating state regarding the first storage apparatus and the second storage apparatus, wherein the operating state indicates among writing, reading, or standing by. A monitor monitors the interfaces and set up the operating state into the status table. A buffer memory buffers the data for writing in the first storage apparatus and the second storage apparatus. A command response unit receives the data for writing and write-in request from a host system, and directs the writing of the data to the first storage apparatus and the second storage apparatus while making the buffer memory buffer the received data.

Abstract: A composition for promoting lacrimal secretion which can be used safely and effectively in the lacrimal secretion promoting therapy, not in the conventional supplemental therapy of lacrimal fluid components is provided. The composition for promoting lacrimal secretion comprising a peptide derivative represented by the formula (I): and a contact lens which retains and/or contains the composition are provided.

Abstract: A controller is connectable to a host system and a plurality of storage devices. A monitor unit monitors operating status of a plurality of storage devices and sets the operating status of the storage devices in a status table. Upon receiving a write command from the host system, a command responding unit receives write data sent from the host system within a certain period of time after the write command, holds the write data received in a buffer memory, instructs a timer to start counting, sets a write destination for data in the status table, outputs a control signal that gives an instruction to write data to the storage device of the write destination, and returns a write completion response corresponding to the write command to the host system when receiving the deadline notification from the timer.

Abstract: A first arithmetic operator (11) includes a first modular arithmetic coding encoder (11b) for encoding a numeric data transmitted by a command from a central controller (31) into a modular arithmetic code, a first arithmetic operation processor (11a) using the numeric data as modular arithmetic coded as an input operand, for executing an arithmetic operation based on a command from the central controller (13), to provide an output in the form of a modular arithmetic code, and a first modular arithmetic code decoder (11c) for determining presence or absence of a bit error in the numeric data output from the first arithmetic operation processor, correcting the bit error, if detected any, to output a decoded numeric data.

Abstract: A composition for promoting lacrimal secretion which can be used safely and effectively in the lacrimal secretion promoting therapy, not in the conventional supplemental therapy of lacrimal fluid components is provided. The composition for promoting lacrimal secretion comprising a peptide derivative represented by the formula (I): and a contact lens which retains and/or contains the composition are provided.

Abstract: For a control apparatus to be boundary scan testable even when running, including processor cores in an operator to be capable of self-repairing a troubling part, an operator (2) has processor cores (2a, 2b) connected to a boundary scan bus (12), and adapted to mutually diagnose opponent processor cores for troubles, by boundary scan testing each other in a time-dividing manner.

Abstract: The present invention provides a bag for packaging medicinal product or a packaging material having excellent long-term storage stability. Specifically, the present invention provides a packaging material that comprises at least a moisture-permeable layer, a moisture-absorption layer, and a shielding layer laminated sequentially, wherein: (1) the moisture-absorption layer is formed of a first composition comprising a moisture absorbent and a resin component; (2) the moisture-permeable layer is formed of a second composition comprising a resin component; and (3) the first composition contains a moisture absorbent in a proportion of 15 wt. % to 60 wt. %.

Abstract: A turntable, swing hammers and fixed teeth of a garbage disposer are combined with a cylindrical pipe in one body, and arranged to be attachable/detachable with respect to a hopper. A guide pipe branching upward from an upstream upper end portion of a S-trap formed in a drainage pipe in the garbage disposer is provided, and a water injection nozzle is set on the guide pipe.

Abstract: To achieve both information confidentiality management and early discovery of information leak.

Abstract: A turntable, swing hammers and fixed teeth of a garbage disposer are combined with a cylindrical pipe in one body, and arranged to be attachable/detachable with respect to a hopper. A guide pipe branching upward from an upstream upper end portion of a S-trap formed in a drainage pipe in the garbage disposer is provided, and a water injection nozzle is set on the guide pipe.

Abstract: The present invention provides a composition for safely and effectively preventing and treating digestive organs diseases, particularly, gastric ulcer, duodenal ulcer, gastritis, diarrhea, enteritis and the like. There is also provided a composition having a novel mechanism of action in order to solve the problems which was difficult to be solved by the side effect previously known mechanisms of action. More particularly, there is provided a pharmaceutical composition containing an ingredient which activates PAR-2 as an essential ingredient, which is useful for inhibiting gastric acid secretion, promoting digestive tract mucus secretion, protecting digestive tract mucosa, repairing tissue of digestive organs, and preventing and treating digestive organs diseases.

Abstract: For a control apparatus to be boundary scan testable even when running, including processor cores in an operator to be capable of self-repairing a troubling part, an operator (2) has processor cores (2a, 2b) connected to a boundary scan bus (12), and adapted to mutually diagnose opponent processor cores for troubles, by boundary scan testing each other in a time-dividing manner.

Abstract: A first arithmetic operator (11) includes a first modular arithmetic coding encoder (11b) for encoding a numeric data transmitted by a command from a central controller (31) into a modular arithmetic code, a first arithmetic operation processor (11a) using the numeric data as modular arithmetic coded as an input operand, for executing an arithmetic operation based on a command from the central controller (13), to provide an output in the form of a modular arithmetic code, and a first modular arithmetic code decoder (11c) for determining presence or absence of a bit error in the numeric data output from the first arithmetic operation processor, correcting the bit error, if detected any, to output a decoded numeric data.

Abstract: A composition for promoting lacrimal secretion which can be used safely and effectively in the lacrimal secretion promoting therapy, not in the conventional supplemental therapy of lacrimal fluid components is provided. The composition comprises a component which activates PAR-2. Also, a contact lens which retains and/or contains said composition for promoting lacrimal secretion is provided.

Abstract: There is disclosed a wiring board comprising a core substrate 110, a build-up layer 130a formed on at least one side of main surfaces the core substrate, wherein a cavity 120 for accommodating a chip-type decoupling capacitor 121 is formed in the build-up layer 130a. The capacitor 121 includes electrode terminals on an upper surface thereof that are directly connected to a semiconductor component, and electrode terminals on a back surface of the capacitor 121 is connected to a wiring conductor layer 132a on a bottom surface of the cavity 120. This structure enables decoupling capacitor and the semiconductor component 260 to be connected with low resistance and low inductance.

Abstract: There is disclosed a wiring board comprising a core substrate 110, a build-up layer 130a formed on at least one side of main surfaces the core substrate, wherein a cavity 120 for accommodating a chip-type decoupling capacitor 121 is formed in the build-up layer 130a. The capacitor 121 includes electrode terminals on an upper surface thereof that are directly connected to a semiconductor component, and electrode terminals on a back surface of the capacitor 121 is connected to a wiring conductor layer 132a on a bottom surface of the cavity 120. This structure enables decoupling capacitor and the semiconductor component 260 to be connected with low resistance and low inductance.

Abstract: A turntable, swing hammers and fixed teeth of a garbage disposer are combined with a cylindrical pipe in one body, and arranged to be attachable/detachable with respect to a hopper. A guide pipe branching upward from an upstream upper end portion of a S-trap formed in a drainage pipe in the garbage disposer is provided, and a water injection nozzle is set on the guide pipe.

Abstract: The present invention provides a composition for safely and effectively preventing and treating digestive organs diseases, particularly, gastric ulcer, duodenal ulcer, gastritis, diarrhea, enteritis and the like. There is also provided a composition having a novel mechanism of action in order to solve the problems which was difficult to be solved by the side effect previously known mechanisms of action. More particularly, there is provided a pharmaceutical composition containing an ingredient which activates PAR-2 as an essential ingredient, which is useful for inhibiting gastric acid secretion, promoting digestive tract mucus secretion, protecting digestive tract mucosa, repairing tissue of digestive organs, and preventing and treating digestive organs diseases.